Caribou Biosciences, Inc. - Common Stock - Nakit Akışı (NASDAQ:CRBU) | MetaTrader

Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

İşletme faaliyetlerinden elde edilen nakit -32.52 M-90.97 M-93.29 M-138.2 M-110.99 M -101.25 M Yatırım faaliyetlerinden elde edilen nakit -176.4 M-93.25 M-68.18 M86.61 M102.24 M 76.84 M Finansman faaliyetlerinden elde edilen nakit 433.43 M2.13 M154.3 M16.72 M4.82 M 7.05 M Serbest nakit akışı -32.52 M-90.97 M-93.29 M-138.2 M-112.35 M -101.64 M

Haberler

Caribou Biosciences, Inc. (CRBU) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates

Qiagen (QGEN) Q1 Earnings and Revenues Lag Estimates

Bristol Myers Squibb: The CAR-T Giant The Market Is Undervaluing (NYSE:BMY)

Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year?

Three Best Genomics Stocks for Your Portfolio in 2026

Sarepta Therapeutics (SRPT) Soars 35.0%: Is Further Upside Left in the Stock?

Caribou Biosciences: Antlers Up For The Allogenic CAR-T Bet Trading At Cash Value

Is CareCloud (CCLD) Outperforming Other Medical Stocks This Year?

Truist, Caribou Biosciences için Al tavsiyesini yineledi, hedef 7 dolar

Truist reiterates Buy on Caribou Biosciences stock, $7 target

Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Tops Revenue Estimates